Identification of potential therapeutic dual inhibitors of EGFR/HER2 in breast cancer

• Autori principali: Megha Jethwa (Autore), Aditi Gangopadhyay (Autore), Achintya Saha (Autore)
• Natura: Libro
• Pubblicazione: Elsevier, 2024-08-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Breast cancer (BC) is the leading cause of death among women worldwide. According to the Breast Cancer Research Foundation (BCRF), 25% of all cases of BC are positive for human epidermal growth factor receptor 2 (HER2), which is the most aggressive phenotype among the five BC subtypes. Previous stud...